Intellia Therapeutics (NASDAQ:NTLA) has outperformed the market over the past 5 years by 33.15% on an annualized basis.
Buying $100 In NTLA: 5 years ago, an investor could have purchased 7.51 shares of Intellia Therapeutics at the time with $100. This investment in NTLA would have produced an average annual return of 47.17%. Currently, Intellia Therapeutics has a market capitalization of $6.87 billion.
Intellia Therapeutics's Share Price Over Last 5 Years
If you had invested $100 in Intellia Therapeutics you would have approximately $693.46 today.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
You can check out Benzinga's market data in an enhanced view on Benzinga Pro
This article was generated by Benzinga's automated content engine and reviewed by an editor.